VetCentric, Inc., a Baltimore, Washington-based company specializing in delivering FDA- and EPA-approved pharmaceuticals, compounded medications, and therapeutic and wellness diets to pet owners on behalf of veterinary clinics, has raised $3m in its Series B funding.
The capital infusion allows VetCentric to further develop its home delivery solution, which enables veterinarians to offer the convenience of home delivery to their clients.
Sherbrooke Capital, the Asset Management Company and the Nestle Venture Capital Fund, part of Nestle S.A., supported the investment equally.
FinSMEs
27/10/2010